chr21-30598804-C-A

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2

The NM_181604.2(KRTAP6-2):​c.71G>T​(p.Gly24Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 31)

Consequence

KRTAP6-2
NM_181604.2 missense

Scores

2
2
11

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.87
Variant links:
Genes affected
KRTAP6-2 (HGNC:18932): (keratin associated protein 6-2) Enables identical protein binding activity. Predicted to be involved in keratinization. Predicted to be located in cytosol. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
KRTAP6-2NM_181604.2 linkuse as main transcriptc.71G>T p.Gly24Val missense_variant 1/1 ENST00000334897.4 NP_853635.1 Q3LI66

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
KRTAP6-2ENST00000334897.4 linkuse as main transcriptc.71G>T p.Gly24Val missense_variant 1/16 NM_181604.2 ENSP00000334560.3 Q3LI66

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
Cov.:
30
GnomAD4 genome
Cov.:
31

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsFeb 23, 2023The c.71G>T (p.G24V) alteration is located in exon 1 (coding exon 1) of the KRTAP6-2 gene. This alteration results from a G to T substitution at nucleotide position 71, causing the glycine (G) at amino acid position 24 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.059
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
16
DANN
Benign
0.93
DEOGEN2
Benign
0.11
T
Eigen
Benign
0.12
Eigen_PC
Benign
0.12
FATHMM_MKL
Uncertain
0.84
D
M_CAP
Benign
0.0089
T
MetaRNN
Uncertain
0.55
D
MetaSVM
Benign
-1.1
T
PROVEAN
Pathogenic
-9.0
D
REVEL
Benign
0.15
Sift4G
Pathogenic
0.0
D
Polyphen
0.79
P
Vest4
0.64
MutPred
0.36
Loss of disorder (P = 0.0099);
MVP
0.26
MPC
0.077
ClinPred
0.74
D
GERP RS
3.5
Varity_R
0.64
gMVP
0.28

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr21-31971123; API